Long-Term immunopersistence and safety of the Escherichia coli-produced HPV-16/18 bivalent vaccine in Chinese adolescent girls
The study assessed long-term immunopersistence and safety of the Escherichia coli (E. coli)-produced HPV-16/18 bivalent vaccine. In total, 979 participants in the initial immunogenicity noninferiority study, including girls aged 9-14 years who were randomized in a 1:1 ratio to receive 2 doses at mon...
Saved in:
Main Authors: | Xingmei Yao (Author), Wengang He (Author), Xianghong Wu (Author), Jianxiang Gu (Author), Jing Zhang (Author), Bizhen Lin (Author), Zhaofeng Bi (Author), Yingying Su (Author), Shoujie Huang (Author), Yuemei Hu (Author), Ting Wu (Author), Jun Zhang (Author), Ningshao Xia (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunogenicity of an Escherichia coli-produced bivalent human papillomavirus vaccine under different vaccination intervals
by: Xiao-Juan Yu, et al.
Published: (2020) -
Lot-to-lot consistency study of an Escherichia coli-produced bivalent human papillomavirus vaccine in adult women: a randomized trial
by: Ying-Ying Su, et al.
Published: (2020) -
Safety and immunogenicity of an Escherichia coli-produced bivalent human papillomavirus type 6/11 vaccine: A dose-escalation, randomized, double-blind, placebo-controlled phase 1 trial
by: Zhao-Jun Mo, et al.
Published: (2022) -
Comparative phenotypic characterization of hybrid Shiga toxin-producing / uropathogenic Escherichia coli, canonical uropathogenic and Shiga toxin-producing Escherichia coli
by: Noble Selasi Gati, et al.
Published: (2021) -
Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study
by: Xingmei Yao, et al.
Published: (2021)